Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 16:13:850334.
doi: 10.3389/fendo.2022.850334. eCollection 2022.

Perirenal Fat Thickness: A Surrogate Marker for Metabolic Syndrome in Chinese Newly Diagnosed Type 2 Diabetes

Affiliations

Perirenal Fat Thickness: A Surrogate Marker for Metabolic Syndrome in Chinese Newly Diagnosed Type 2 Diabetes

Xiu Li Guo et al. Front Endocrinol (Lausanne). .

Abstract

Objective: Increasing evidence suggested that perirenal fat thickness (PrFT) was associated with metabolic risk factors. This study aimed to assess the association between PrFT and metabolic syndrome (MetS) in Chinese newly diagnosed type 2 diabetes (T2DM), further evaluating the ability of PrFT in identifying MetS.

Method: A total of 445 Chinese newly diagnosed T2DM were enrolled in this study from January to June 2021. Demographic and anthropometric information were collected. PrFT was evaluated by CT scan on Revolution VCT 256. MetS was based on the Chinese Diabetes Society definition. Receiver operating characteristic (ROC) curve was conducted to assess the optimal cutoff value of PrFT in identifying MetS.

Results: Overall, the prevalence of MetS was 57.5% (95% CI: 54.0-64.0%) in men and 58.9% (95% CI: 52.3-65.5%) in women separately. The correlation analysis showed that PrFT was significantly correlated with metabolic risk factors like body mass index, waist circumference, triglycerides, high-density lipoprotein cholesterol, systolic blood pressure, diastolic blood pressure, uric acid, and insulin resistance. PrFT was also shown to be independently associated with MetS after adjustment for other confounders. The odds ratios (ORs, 95% CI) were 1.15 (1.03-1.38) in men and 1.31 (1.08-1.96) in women (P < 0.05). The ROC curves showed a good predictive value of PrFT for MetS. The areas under the curve of PrFT identifying MetS were 0.895 (95% CI: 0.852-0.939) in men and 0.910 (95% CI: 0.876-0.953) in women (P < 0.001). The optimal cutoff values of PrFT were 14.6 mm (sensitivity: 83.8%, specificity: 89.6%) for men and 13.1 mm (sensitivity: 87.6%, specificity: 91.1%) for women.

Conclusions: PrFT was significantly associated with MetS and showed a powerful predictive value for it, which suggested that PrFT can be an applicable surrogate marker for MetS in Chinese newly diagnosed T2DM.

Clinical trial registration: This study was registered in clinicaltrials.gov (ChiCTR2100052032).

Keywords: metabolic syndrome; newly diagnosed type 2 diabetes; optimal cut-off value; perirenal fat thickness; visceral adipose tissue.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The average of maximal thickness values (blue line) between the posterior wall of the kidney and the inner limit of the abdominal wall across the renal venous plane was calculated as the PrFT.
Figure 2
Figure 2
Flow diagram of the patients excluded and included in this study.
Figure 3
Figure 3
Receiver operating characteristic curves for the cutoff value of PrFT to identify MetS. In men, the area under the curve was 0.895 (95% CI: 0.852–0.939). In women, the area under the curve was 0.910 (95% CI: 0.876–0.953). The optimal cutoff values of PrFT were 14.6 mm (sensitivity: 83.8%, specificity: 89.6%) for men and 13.1 mm (sensitivity: 87.6%, specificity: 91.1%) for women.

Similar articles

Cited by

References

    1. Zimmet P, alberti G, Kaufman F, Tajima N, Silink M, Arslanian S, et al. . The Metabolic Syndrome in Children and Adolescents. Lancet (London England) (2007) 369(9579):2059–61. doi: 10.1016/S0140-6736(07)60958-1 - DOI - PubMed
    1. LI X, Cao C, Tang X, Yan X, Zhou H, Liu J, et al. . Prevalence of Metabolic Syndrome and Its Determinants in Newly-Diagnosed Adult-Onset Diabetes in China: A Multi-Center, Cross-Sectional Survey. Front Endocrinol (2019) 10):661. doi: 10.3389/fendo.2019.00661 - DOI - PMC - PubMed
    1. Chen W, Pan Y, Jing J, Zhao X, Liu L, Meng X, et al. . Recurrent Stroke in Minor Ischemic Stroke or Transient Ischemic Attack With Metabolic Syndrome and/or Diabetes Mellitus. J Am Heart Assoc (2017) 6(6):e005446. doi: 10.1161/JAHA.116.005446 - DOI - PMC - PubMed
    1. Fujiyoshi A, Murad MH, Luna M, Rosario A, Ali S, Paniagua D, et al. . Metabolic Syndrome and Its Components are Underdiagnosed in Cardiology Clinics. J Eval Clin Pract (2011) 17:78–83. doi: 10.1111/j.1365-2753.2010.01371.x - DOI - PubMed
    1. Kuk J, Church T, Blair S, Ross R. Does Measurement Site for Visceral and Abdominal Subcutaneous Adipose Tissue Alter Associations With the Metabolic Syndrome? Diabetes Care (2006) 29(3):679–84. doi: 10.2337/diacare.29.03.06.dc05-1500 - DOI - PubMed